Pedro Dorado

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 10

Top Topics

Rheumatoid Arthritis

Idiopathic Pulmonary Fibrosis

Genome Wide Analysis

Clinical Decision Support

Top Venues

Pharmacogenomics

Journal of personalized medicine

The pharmacogenomics journal

This page only lists publications with an associated author ORCID identifier.

Publications

Pedro Dorado, Eva M Peñas-Lledó
Pharmacogenetic and pharmacogenomic treatment of rheumatoid arthritis: a review of Pharmacogenomics Knowledge Base scientific evidence. Pharmacogenomics 25 (2) (2024)
Pedro Dorado, Eva M Peñas-Lledó
Pharmacogenetic and pharmacogenomic treatment of rheumatoid arthritis: a review of Pharmacogenomics Knowledge Base scientific evidence. Pharmacogenomics 25 (2) (2024)
Pedro Dorado, Eva M Peñas-Lledó
Pharmacogenetic and pharmacogenomic treatment of rheumatoid arthritis: a review of Pharmacogenomics Knowledge Base scientific evidence. Pharmacogenomics (2024)
Pedro Dorado, Eva M Peñas-Lledó
Pharmacogenetic and pharmacogenomic treatment of rheumatoid arthritis: a review of Pharmacogenomics Knowledge Base scientific evidence. Pharmacogenomics 25 (2) (2024)
Francisco C Ceballos, Eugenio Chamizo-Carmona, Carmen Mata-Martín, Carmen Carrasco-Cubero, Juan J Aznar-Sánchez, Raúl Veroz-González, Sara Rojas-Herrera, Pedro Dorado, Adrián LLerena
Pharmacogenetic Sex-Specific Effects of Methotrexate Response in Patients with Rheumatoid Arthritis. Pharmaceutics 15 (6) (2023)
Francisco C Ceballos, Eugenio Chamizo-Carmona, Carmen Mata-Martín, Carmen Carrasco-Cubero, Juan J Aznar-Sánchez, Raúl Veroz-González, Sara Rojas-Herrera, Pedro Dorado, Adrián LLerena
Pharmacogenetic Sex-Specific Effects of Methotrexate Response in Patients with Rheumatoid Arthritis. Pharmaceutics 15 (6) (2023)
Pedro Dorado, Gracia Santos-Díaz, Yolanda Gutiérrez-Martín, Miguel Ángel Suárez-Santisteban
Frequency of CYP2C9 Promoter Variable Number Tandem Repeat Polymorphism in a Spanish Population: Linkage Disequilibrium with CYP2C9*3 Allele. Journal of personalized medicine 12 (5) (2022)
Ingrid Fricke-Galindo, Helgi Jung-Cook, Iris E Martínez-Juárez, Nancy Monroy-Jaramillo, Alberto Ortega-Vázquez, Irma S Rojas-Tomé, Pedro Dorado, Eva M Peñas-Lledó, Adrián LLerena, Marisol López-López
Relevance of NR1I2 variants on carbamazepine therapy in Mexican Mestizos with epilepsy at a tertiary-care hospital. Pharmacogenomics 22 (15) (2021)
Fernando de Andrés, Catalina Altamirano-Tinoco, Ronald Ramírez-Roa, Carlos F Montes-Mondragón, Pedro Dorado, Eva M Peñas-Lledó, Adrián LLerena
Relationships between CYP1A2, CYP2C9, CYP2C19, CYP2D6 and CYP3A4 metabolic phenotypes and genotypes in a Nicaraguan Mestizo population. The pharmacogenomics journal 21 (2) (2020)
Alba P Sarmiento, Pedro Dorado, Angélica Borbón, Fernando de Andrés, Adrián LLerena, null null
High prevalence of CYP2D6 ultrarapid metabolizers in a mestizo Colombian population in relation to Hispanic mestizo populations. Pharmacogenomics 21 (17) (2020)